Literature DB >> 13799049

The effect of dl-3,3',5'-triiodothyronine in Graves' disease.

R S BENUA, S KUMAOKA, R D LEEPER, R W RAWSON.   

Abstract

Entities:  

Keywords:  HYPERTHYROIDISM/therapy; TRIIODOTHYRONINE/pharmacology

Mesh：

Substances：

Year:  1959        PMID： 13799049     DOI： 10.1210/jcem-19-10-1344

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Inhibition of L-thyroxine monodeiodination by thyroxine analogs.

Authors:  F C LARSON; E C ALBRIGHT
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

2.  The importance of reverse triiodothyronine in hypothyroid children on replacement treatment.

Authors:  M Desai; A J Irani; K Patil; C S Pandya
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

3.  Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents.

Authors:  D L St Germain
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.